Filing Details

Accession Number:
0001213900-20-039338
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-11-25 16:50:03
Reporting Period:
2018-07-31
Accepted Time:
2020-11-25 16:50:03
Original Submission Date:
2018-08-02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513525 Adial Pharmaceuticals Inc. ADIL Pharmaceutical Preparations (2834) 800667150
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1718094 Kevin Schuyler 1180 Seminole Trail, Suite 495
Charlottesville VA 22901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-31 89,600 $0.00 222,990 No 4 J Direct
Common Stock Acquisiton 2018-07-31 90,000 $0.00 312,990 No 4 P Direct
Common Stock Acquisiton 2018-07-31 144,200 $0.00 144,200 No 4 J Indirect Owned by MVA 151 Investors, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 P Direct
No 4 J Indirect Owned by MVA 151 Investors, LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to purchase common stock Acquisiton 2018-07-31 89,600 $0.00 89,600 $6.25
Common Stock Warrant to purchase common stock Acquisiton 2018-07-31 90,000 $0.00 90,000 $6.25
Common Stock Warrant to purchase common stock Acquisiton 2018-07-31 192,600 $0.00 192,200 $6.25
Units Warrant to purchase units Acquisiton 2018-07-31 89,600 $0.00 179,200 $5.00
Units Warrant to purchase units Acquisiton 2018-07-31 192,600 $0.00 385,200 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
89,600 2018-07-31 2023-07-31 No 4 J Direct
90,000 2018-07-31 2023-07-31 No 4 P Direct
192,600 2018-07-31 2023-07-31 No 4 J Indirect
89,600 2018-07-31 2023-07-31 No 4 J Direct
192,600 2018-07-31 2023-07-31 No 4 J Indirect
Footnotes
  1. The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect 89,600 shares of common stock and warrants to purchase 89,600 shares of common stock that were received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018.
  2. The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect 192,600 shares of common stock and warrants to purchase 192,600 shares of common stock were received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018.
  3. The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect the purchase 89,600 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 179,200 shares.
  4. The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect 192,600 units was received by MVA 151 Investors LLC upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 385,200 shares.
  5. Mr. Schuyler has control over MVA 151 Investors, LLC.
  6. The original warrant number and units issuable upon exercise of the warrant is being corrected to reflect On July 31, 2018, Mr. Schuyler purchased 90,000 units (the "Units") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering.